Loading your page…

Pharmaceutical group

SIFI

39 medicines6 countries

A group of 5 companies with 39 medicines in 6 countries.

Its medicines

Group structure

5 companies in 3 countries

Italy3

Canada1

Sifi North America Inc./ Sifi Amerique du Nord Inc.Authorisation holder · 1 medicine

United Kingdom1

Sifi Pharmaceuticals LimitedAuthorisation holder

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

1–25 of 39

Medicine	Substance	Country	Status	Authorised
Akantior	Polihexanide	EU (EMA)	Authorised	2024
AKANTIORCollirio, soluzione	Polihexanide	Italy	Authorised
AKANTIOR 0,8 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS0,8 mg/ml · Colirio en solución en envase unidosis	Polihexanide	Spain	Marketed	2024
AKANTIOR 0,8 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikOogdruppels, oplossing	Polihexanide	Netherlands	Authorised	2024
AMIRIOXCollirio, soluzione	Bimatoprost	Italy	Authorised
AMIRIOX 0,3 MG/ML COLIRIO EN SOLUCION0,3 mg/ml · Colirio en solución	Bimatoprost	Spain	Marketed	2021
CARTEOLCollirio, soluzione	Carteolol	Italy	Authorised
COLBIOCINCollirio, polvere e solvente per soluzione	Chloramphenicol, Colistin, Tetracycline	Italy	Authorised
ECBIRIOCollirio, soluzione	Bimatoprost, Timolol	Italy	Authorised
ECBIRIO 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION0,3 mg + 6,83 mg · Colirio en solución	Bimatoprost, Timolol	Spain	Marketed	2020
Ecbirio 0,3 mg/ml + 5 mg/ml oogdruppels, oplossingOogdruppels, oplossing	Bimatoprost, Timolol	Netherlands	Authorised	2020
ETACORTILENCollirio, soluzione	Desametasone	Italy	Authorised
ETACORTILEN 1,5 MG/ML COLIRIO EN SOLUCION1,5 mg · Colirio en solución	Dexamethasone	Spain	Marketed	2019
Etacortilen 1,5 mg/ml oogdruppels, oplossingOogdruppels, oplossing	Dexamethasone	Netherlands	Authorised	2020
GELISIA 1 MG/G GEL OFTALMICO1,37 mg · Gel oftálmico	Timolol	Spain	Authorised	2023
Gelisia 1 mg/g, ooggel in verpakking voor éénmalig gebruikOoggel	Timolol	Netherlands	Authorised	2023
GENISIAGel oftalmico in contenitore monodose	Timolol	Italy	Authorised
HYALISTILCollirio, soluzione	Ialuronato	Italy	Authorised
IDRASTILCollirio, soluzione	Acido ialuronico	Italy	Authorised
IOPIZECollirio, soluzione	Latanoprost	Italy	Authorised
LATANOPROST SIFICollirio, soluzione	Latanoprost	Italy	Authorised
LATATIMCollirio, soluzione	Latanoprost, Timolol	Italy	Authorised
MIRTILENECapsula molle	Mirtillo nero estratto secco idroalcolico, D-l-alfa-tocoferil, Beta-carotene	Italy	Authorised
NETDEX 3 MG/ML + 1 MG/ML COLIRIO EN SOLUCION4,55 mg + 1,32 mg · Colirio en solución	Netilmicin, Dexamethasone	Spain	Marketed	2020
NETDEX 3 MG/ML + 1 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS1,32 mg + 4,55 mg · Colirio en solución en envase unidosis	Dexametasona disodio, Netilmicin	Spain	Marketed	2020

Sources and licences

Country	Medicines	Current	Past	Companies
Italy	17	17	0	Companies All medicines
Spain	10	10	0	Companies All medicines
Netherlands	4	4	0	Companies All medicines
Romania	4	0	4	Companies All medicines
Canada	3	2	1	Companies All medicines
European Union (EMA)	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

All 18 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removalCorrections from the company itself are welcome.

SIFI

Group structure

Italy3

Canada1

United Kingdom1

Medicines

Know your medicines, with the sources.

SIFI

Group structure

Italy3

Canada1

United Kingdom1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇮🇹Italy3

🇨🇦Canada1

🇬🇧United Kingdom1

Medicines

Know your medicines, with the sources.

Group structure

🇮🇹Italy3

🇨🇦Canada1

🇬🇧United Kingdom1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Italy3

Canada1

United Kingdom1

Italy3

Canada1

United Kingdom1